Conference Abstracts

181 results

Warm Homes, Better Breathing: A Neighbourhood Approach to Supporting Respiratory Patients Affected by Fuel Poverty (ID 824)

Clarke R, Green D, Tinnion P, Southern S, Astbury A

Health Innovation North West Coast

Improving COPD Rescue Pack Management in a Deprived Primary Care Network: A Pharmacy Technician-Led Pilot (ID 825)

Kadar D, Burns S, Ahmed A, Tariq B, Keane L, Dr Razvi A.

Liverpool First Primary Care Network

When Biomarkers Mislead: The Impact of Comorbid Disease and Smoking in Severe Asthma (ID 826)

Abou Swid L, Muthiaihpillai K, Ganendiran K, Vijayanand ALA, Jackson D

King's College London

A Breath of Fresh AIR: A Two-Cycle Primary Care Service Improvement Project to Reduce SABA Monotherapy (ID 827)

Hamilton H, Dewar J, Cooper S

Pioneer Medical Group

Improving COPD Outcomes in Primary Care Through Holistic Reviews, Inhaler Optimisation and Multimorbidity Management (ID 828)

Hardaker L

Priory Medical Group, Haxby Group Practice, Selby Town PCN and York Medical Group in York, North Yorkshire

Integrated COPD Optimisation in Primary Care: Improving Outcomes Through Inhaler Technique and Multimorbidity Management (ID 829)

Latife Hardaker¹
¹Priory Medical Group /Haxby Group Practice/Selby Town PCN,York Medical Group

Priory Medical Group, Haxby Group Practice, Selby Town PCN and York Medical Group in York, North Yorkshire

A service improvement project to harness the benefits of ICS/Formoterol reliever therapy for patients attending the Emergency Department for acute exacerbations of asthma (ID 830)

Wiffen L, De Vos R, Lizarondo M, Herbert S, Brown TP

Portsmouth Hospitals University NHS Trust

Asthma and COPD Winter Burden Study: Assessment of the winter burden of asthma and COPD after treatment review. (ID 831)

Pfeffer P, Hale MJ, Watt M, Chiu G, Lipworth J, Murphy A

AstraZeneca

Of Self-Management and Sandwiches: Time Pressure, Resistance, and Lunch Hour Online Asthma Care Improvement (ID 832)

Korell B, Bezemer J, Taylor SJC, Pinnock H, Steed L

Queen Mary, University of London

The inherent variability of asthma: implications for diagnosis and assessing response to treatment (ID 833)

Ghafoor M, Bennett M, Wang R, Simpson A, Murray CS, Fowler SJ

University of Manchester, Division of Infection, Immunity and Respiratory Medicine, Manchester University NHS Foundation Trust, Department of Allergy & Respiratory Medicine

From breathlessness to action: Understanding help-seeking behaviours and preferred support strategies for breathlessness in a South Asian focus group (ID 834)

Akosile PA, Evans RE, Miah NM and Doe GD

University of Leicester

Identifying unmet COPD need by delivering pharmacist-led risk stratification and optimisation at scale in primary care in 2025. (ID 835)

Kang A

Screen Clinical

Offering home sensors to families of children with high-risk respiratory conditions: a feasibility study to connect NHS and housing pathways (ID 836)

Adegboye O, Ali S, Littleford K, Sheringham J

University College London (UCL)

Optimising opportunities for capacity building within programme grants: the example of the IMP2ART programme (ID 837)

Pinnock H, Hammersley V, Delaney B, Kinley E, Korell B, McClatchey K, Uzzaman N, Sheringham J, Steed L, MacLeod C, Taylor S on behalf of the IMP2ART investigators.

The University of Edinburgh

Respiratory Specialist Review Service: Improving Access to Respiratory Expertise Through a Multi-Neighbourhood-Based Model of Care (ID 838)

Grant N, Swallow M, Carter L

SDS Respiratory Specialist Review Service

Transforming Asthma Management in Primary Care: A Pharmacist-Led Asthma Education and Medicines Optimisation Programme (ID 839)

Obhi, S

Nuneaton and Bedworth Primary Care Network

Beyond trial outcomes: Process evaluation insights into the IMP2ART trial findings. (ID 840)

MacLeod C, Sheringham J, Steed L, Delaney B, Marsh V, Hammersley V, McClatchey K, Taylor SJC, Pinnock H

University of Edinburgh

How health economics can move us beyond efficiency to equity in asthma care: the IMP2ART E study (ID 841)

Jones M, Davies Ff, Driscoll TJ, Parsons J, Fitzsimmons D, Hammersley V, Jackson T, O'Neill C, Pinnock H, Sheringham J, Macleod C

Swansea University

IMProving IMPlementation of Asthma self-management as Routine (IMP2ART) trial: health economic evaluation (ID 842)

Driscoll T, Jones M, Davies Ff, Fitzsimmons D, Hamborg T, Hammersley V, Jackson T, Macleod C, Sheringham J, Stuart B, Taylor S, Pinnock H,

Swansea University

Optimising care for patients with COPD through pharmacist-led therapy reviews in line with NHS priorities (ID 843)

Jungius E, Gallagher J, Jessop L, Hughes T

IQVIA Interface Clinical Services

Beyond trial outcomes: Contextual insights into the IMP2ART trial findings (ID 844)

Sheringham J, Steed L, MacLeod C, Hammersley V, Taylor SJC, Pinnock H.

The University of Edinburgh

Psychometric evaluation of the Portsmouth Inhaler Technique (PIT) Score: discriminant validity, reliability and internal consistency (ID 845)

De Vos R, Lomax M, Mackenzie H, Longstaff J, Kostakis I, Chauhan M, Clark R, Neville D, Jones TL, Sanders M, Brown TP, Chauhan AJ.

Portsmouth Hospitals University NHS Trust

Reaching the “Unreached”: A Pharmacist-Led Community Respiratory Service Improving Equity and Outcomes in Childhood Asthma (ID 846)

Hussain N, Afzal I, Zaman I, Hussain I

Dudley Integrated Health and Care NHS Trust

A SECONDARY ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY OF V116, A PNEUMOCOCCAL CONJUGATE VACCINE, IN CHILDREN AND ADOLESCENTS WITH INCREASED RISK OF PNEUMOCOCCAL DISEASE (STRIDE-013) (ID 847)

Jagannath V, Pathirana J, Chapman T, Zeng T, Euler D, Papa M, Fernsler D, Park J, Esteves-Jaramillo A, Platt H, for the STRIDE-013 study group. Presented on behalf of the authors by Patel J

MSD (UK)

A SUBGROUP ANALYSIS OF A PHASE 3, RANDOMIZED TRIAL INVESTIGATING SAFETY AND IMMUNOGENICITY OF V116 IN VACCINE-NAÏVE ADULTS AT INCREASED RISK OF PNEUMOCOCCAL DISEASE (STRIDE-8) (ID 848)

Scott P, Pathirana J, Falk Russell A, Fernsler D, Waleed M, Li J, Buchwald U, Esteves-Jaramillo A, and Platt H, for the STRIDE-8 Study Group. Presented on behalf of the authors by Patel J.

MSD (UK)